Umbilical cord-derived mesenchymal stem cells alleviated inflammation and inhibited apoptosis in interstitial cystitis via AKT/mTOR signaling pathway

Biochemical and Biophysical Research Communications

Volumn 495, Issue 1, 2018, Pages 546-552

  Xie, Juncong ^a   Liu, Bolong ^a   Chen, Jialiang ^a   Xu, Yuancheng ^a   Zhan, Hailun ^a   Yang, Fei ^a   Li, Wenbiao ^a   Zhou, Xiangfu ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Apoptosis; Cystitis; Inflammation; Stem cells

Indexed keywords

CASPASE 3; EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR; MTOR PROTEIN, RAT; ONCOPROTEIN; TARGET OF RAPAMYCIN KINASE;

AKT/MTOR SIGNALING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL INFILTRATION; CELLULAR SECRETION; COCULTURE; CONTROLLED STUDY; CYCLOPHOSPHAMIDE-INDUCED CYSTITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERSTITIAL CYSTITIS; MAST CELL; MESENCHYMAL STEM CELL; MICTURITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT MODEL; STEM CELL TRANSPLANTATION; SV-HUC-1 CELL LINE; UMBILICAL CORD DERIVED MESENCHYMAL STEM CELL; WESTERN BLOTTING; ANIMAL; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; IMMUNOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PATHOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; CORD BLOOD STEM CELL TRANSPLANTATION; CYSTITIS, INTERSTITIAL; FEMALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; ONCOGENE PROTEIN V-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TREATMENT OUTCOME;

EID: 85035149596     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2017.11.072     Document Type: Article

References (35)

1. Hanno, P.M., Erickson, D., Moldwin, R., Faraday, M.M., American Urological, A., Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J. Urol. 193 (2015), 1545–1553.
2. Nickel, J.C., Tripp, D.A., Pontari, M., Moldwin, R., Mayer, R., Carr, L.K., Doggweiler, R., Yang, C.C., Mishra, N., Nordling, J., Psychosocial phenotyping in women with interstitial cystitis/painful bladder syndrome: a case control study. J. Urol. 183 (2010), 167–172.
3. Slobodov, G., Feloney, M., Gran, C., Kyker, K.D., Hurst, R.E., Culkin, D.J., Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J. Urol. 171 (2004), 1554–1558.
4. Min, G., Zhou, G., Schapira, M., Sun, T.T., Kong, X.P., Structural basis of urothelial permeability barrier function as revealed by Cryo-EM studies of the 16 nm uroplakin particle. J. Cell Sci. 116 (2003), 4087–4094.
5. Lee, J.D., Lee, M.H., Decreased expression of zonula occludens-1 and occludin in the bladder urothelium of patients with interstitial cystitis/painful bladder syndrome. J. Formos. Med. Assoc. 113 (2014), 17–22.
6. Kim, A., Shin, D.M., Choo, M.S., Stem cell therapy for interstitial cystitis/bladder pain syndrome. Curr. Urol. Rep., 17, 2016, 1.
7. Satija, N.K., Singh, V.K., Verma, Y.K., Gupta, P., Sharma, S., Afrin, F., Sharma, M., Sharma, P., Tripathi, R.P., Gurudutta, G.U., Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J. Cell Mol. Med. 13 (2009), 4385–4402.
8. Song, M., Heo, J., Chun, J.Y., Bae, H.S., Kang, J.W., Kang, H., Cho, Y.M., Kim, S.W., Shin, D.M., Choo, M.S., The paracrine effects of mesenchymal stem cells stimulate the regeneration capacity of endogenous stem cells in the repair of a bladder-outlet-obstruction-induced overactive bladder. Stem Cells Dev. 23 (2014), 654–663.
9. Nicolay, N.H., Lopez Perez, R., Debus, J., Huber, P.E., Mesenchymal stem cells - a new hope for radiotherapy-induced tissue damage?. Cancer Lett. 366 (2015), 133–140.
10. Minguell, J.J., Allers, C., Lasala, G.P., Mesenchymal stem cells and the treatment of conditions and diseases: the less glittering side of a conspicuous stem cell for basic research. Stem Cells Dev. 22 (2013), 193–203.
11. Kuchroo, P., Dave, V., Vijayan, A., Viswanathan, C., Ghosh, D., Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway. Stem Cells Dev. 24 (2015), 437–450.
12. Chen, Y.T., Chiang, H.J., Chen, C.H., Sung, P.H., Lee, F.Y., Tsai, T.H., Chang, C.L., Chen, H.H., Sun, C.K., Leu, S., Chang, H.W., Yang, C.C., Yip, H.K., Melatonin treatment further improves adipose-derived mesenchymal stem cell therapy for acute interstitial cystitis in rat. J. Pineal Res. 57 (2014), 248–261.
13. Song, M., Lim, J., Yu, H.Y., Park, J., Chun, J.Y., Jeong, J., Heo, J., Kang, H., Kim, Y., Cho, Y.M., Kim, S.W., Oh, W., Choi, S.J., Jang, S.W., Park, S., Shin, D.M., Choo, M.S., Mesenchymal stem cell therapy alleviates interstitial cystitis by activating Wnt signaling pathway. Stem Cells Dev. 24 (2015), 1648–1657.
14. Hirose, Y., Yamamoto, T., Nakashima, M., Funahashi, Y., Matsukawa, Y., Yamaguchi, M., Kawabata, S., Gotoh, M., Injection of dental pulp stem cells promotes healing of damaged bladder tissue in a rat model of chemically induced cystitis. Cell Transpl. 25 (2016), 425–436.
15. Rooney, P., Srivastava, A., Watson, L., Quinlan, L.R., Pandit, A., Hyaluronic acid decreases IL-6 and IL-8 secretion and permeability in an inflammatory model of interstitial cystitis. Acta Biomater. 19 (2015), 66–75.
16. Schrepf, A., O'Donnell, M., Luo, Y., Bradley, C.S., Kreder, K., Lutgendorf, S., N, Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research, Inflammation and inflammatory control in interstitial cystitis/bladder pain syndrome: associations with painful symptoms. Pain 155 (2014), 1755–1761.
17. Gonzalez, E.J., Arms, L., Vizzard, M.A., The role(s) of cytokines/chemokines in urinary bladder inflammation and dysfunction. Biomed. Res. Int., 2014, 2014, 120525.
18. Liu, B.L., Yang, F., Zhan, H.L., Feng, Z.Y., Zhang, Z.G., Li, W.B., Zhou, X.F., Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial cystitis/bladder pain syndrome. Urol. Int. 92 (2014), 202–208.
19. Sargent, A., Miller, R.H., MSC therapeutics in chronic inflammation. Curr. Stem Cell Rep. 2 (2016), 168–173.
20. Li, R., Zhang, Y., Zheng, X., Peng, S., Yuan, K., Zhang, X., Min, W., Synergistic suppression of autoimmune arthritis through concurrent treatment with tolerogenic DC and MSC. Sci. Rep., 7, 2017, 43188.
21. Xiang, B., Chen, L., Wang, X., Zhao, Y., Wang, Y., Xiang, C., Transplantation of menstrual blood-derived mesenchymal stem cells promotes the repair of LPS-induced acute lung injury. Int. J. Mol. Sci., 18, 2017.
22. Munneke, J.M., Spruit, M.J., Cornelissen, A.S., van Hoeven, V., Voermans, C., Hazenberg, M.D., The potential of mesenchymal stromal cells as treatment for severe steroid-refractory acute graft-versus-host disease: a critical review of the literature. Transplantation 100 (2016), 2309–2314.
23. Parsons, C.L., The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology 69 (2007), 9–16.
24. Lee, J.D., Lee, M.H., Activation of extrinsic apoptotic pathway from bladder biopsy in patients with interstitial cystitis/painful bladder syndrome, Urology., 82, 2013 1451 e1457–1411.
25. Shie, J.H., Liu, H.T., Kuo, H.C., Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis/painful bladder syndrome, Urology., 79, 2012 484 e487–413.
26. Mesentier-Louro, L.A., Zaverucha-do-Valle, C., Rosado-de-Castro, P.H., Silva-Junior, A.J., Pimentel-Coelho, P.M., Mendez-Otero, R., Santiago, M.F., Bone marrow-derived cells as a therapeutic approach to optic nerve diseases. Stem Cells Int., 2016, 2016, 5078619.
27. Chen, D., Hao, H., Fu, X., Han, W., Insight into reepithelialization: how do mesenchymal stem cells perform?. Stem Cells Int., 2016, 2016, 6120173.
28. Pers, Y.M., Ruiz, M., Noel, D., Jorgensen, C., Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives. Osteoarthr. Cartil. 23 (2015), 2027–2035.
29. Santos Nascimento, D., Mosqueira, D., Sousa, L.M., Teixeira, M., Filipe, M., Resende, T.P., Araujo, A.F., Valente, M., Almeida, J., Martins, J.P., Santos, J.M., Barcia, R.N., Cruz, P., Cruz, H., Pinto-do, O.P., Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms. Stem Cell Res. Ther., 5, 2014, 5.
30. Adamowicz, J., Pokrywczynska, M., Drewa, T., Conditioned medium derived from mesenchymal stem cells culture as a intravesical therapy for cystitis interstitials. Med. Hypotheses 82 (2014), 670–673.
31. Diaz, M.E., Gonzalez, L., Miquet, J.G., Martinez, C.S., Sotelo, A.I., Bartke, A., Turyn, D., Growth hormone modulation of EGF-induced PI3K-Akt pathway in mice liver. Cell Signal 24 (2012), 514–523.
32. Zhao, L., Liu, X., Zhang, Y., Liang, X., Ding, Y., Xu, Y., Fang, Z., Zhang, F., Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction. Exp. Cell Res. 344 (2016), 30–39.
33. Hubbard, P.A., Moody, C.L., Murali, R., Allosteric modulation of Ras and the PI3K/AKT/mTOR pathway: emerging therapeutic opportunities. Front. Physiol., 5, 2014, 478.
34. Chang, L., Graham, P.H., Hao, J., Ni, J., Bucci, J., Cozzi, P.J., Kearsley, J.H., Li, Y., Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance. Cell Death Dis., 4, 2013, e875.
35. Li, J., Huang, S., Zhang, J., Feng, C., Gao, D., Yao, B., Wu, X., Fu, X., Mesenchymal stem cells ameliorate inflammatory cytokine-induced impairment of AT-II cells through a keratinocyte growth factor-dependent PI3K/Akt/mTOR signaling pathway. Mol. Med. Rep. 13 (2016), 3755–3762.